Zentiva
Tomas Petrla is an experienced professional in the pharmaceutical industry, currently serving as the Head of Investment and Engineering at Zentiva since May 2018. Responsibilities include leading a department comprising four teams, managing organizational compliance with GMP and HSE standards, overseeing investment planning and financial management, and driving efficiency through optimization and digitalization projects. Previous roles at Zentiva included interim LEAN manager and production manager, where Tomas led teams, implemented LEAN methodologies, and managed production processes for oral solid dosage forms. Prior experience includes a tenure at TEVA Czech Industries as production manager for oral solid dosage forms and as a technologist/process engineer, with a focus on production technology and process setup. Early career roles encompassed technical positions in liquid dosage forms at Pliva - Lachema a. s., providing a solid foundation in sterile and cytostatic productions.
This person is not in any teams
Zentiva
5 followers
Zentiva is a Pan-European Platform developing, manufacturing and providing high-quality and affordable medicines to more than 100 million people in Europe. Zentiva has 4 wholly owned manufacturing sites and a broad network of external manufacturing partners to ensure supply security. We offer solutions in key therapeutical areas like Cardiology & Circulation, Diabetes, Oncology, Respiratory, CNS and focus on expanding our portfolio in self-care. The company is Private Equity owned, delivering sustainable double-digit growth, with an ambitious 5-year plan for further strong (organic and inorganic) growth across Europe. We are a team of almost 5,000 unique talents bonded together by our mission to deliver high-quality and affordable medicines to people who depend on them every day. We want Zentiva to be a great place to work, where everyone feels welcomed and appreciated and can be their true selves contributing to the best of their ability.